Skip to main content
NVDA-2.45%AAPL+2.59%GOOGL+0.45%MSFT-0.04%AMZN-0.07%TSM-1.20%SPCX+1.15%AVGO-0.54%META-0.77%TSLA-0.64%SKHY-3.86%MU-4.52%BRK-B-0.16%LLY+0.40%JPM-0.53%WMT+0.12%AMD-2.80%V-0.31%XOM+0.85%ASMLa-1.66%JNJ+0.01%INTC-4.89%MA-0.58%0700.HK-1.94%1398.HK+0.79%ORCL-3.73%ABBV+0.69%BAC-0.47%CSCO-1.32%CVX-0.09%COST-0.15%KO+0.66%LRCX-4.97%CAT-1.40%AP2d-1.55%0005.HK-0.78%AMAT-2.47%UNH-0.55%HSBA.L-1.30%DELL-3.92%PG+0.14%MS-0.99%GE-0.74%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX+0.02%HD-1.60%0939.HK+1.66%GS-1.00%NZDJPY-2.57%AUDJPY-1.80%CHFJPY-1.58%NZDCAD-1.44%EURNZD+1.42%NZDUSD-1.38%GBPNZD+1.37%USDJPY-1.22%GBPJPY-1.21%EURJPY-1.20%CADJPY-1.15%NZDCHF-1.03%USDZAR+1.02%USDSEK+0.88%EURZAR+0.87%USDNOK+0.86%AUDNZD+0.80%GBPZAR+0.79%EURSEK+0.73%EURNOK+0.72%AUDCAD-0.68%AUDDKK-0.64%EURAUD+0.61%USDTHB+0.60%AUDUSD-0.58%GBPAUD+0.57%CHFSEK+0.57%CHFNOK+0.55%AUDSGD-0.53%USDMXN+0.44%CADCHF+0.42%USDPLN+0.41%GBPTRY+0.41%NZDSGD-0.40%EURCHF+0.38%USDCHF+0.37%GBPCHF+0.35%NOKJPY-0.34%GBPHKD+0.32%GBPMXN-0.28%SGDJPY+0.26%EURPLN+0.26%USDSGD+0.25%NZDMXN-0.23%AUDCHF-0.22%USDILS+0.16%EURHKD-0.16%USDDKK+0.15%USDTRY+0.11%PLNJPY+0.11%EURSGD+0.11%USDCNH+0.10%EURCZK-0.09%GBPCAD-0.08%AUDNOK+0.07%USDCAD-0.06%CHFSGD-0.06%EURCAD-0.05%USDCOP-0.04%EURGBP+0.03%EURCNH-0.03%GBPSGD+0.02%EURUSD+0.02%USDHKD+0.01%GBPUSD+0.01%EURDKK0.00%XPTUSD-5.82%UKOIL+5.74%USOIL+5.51%GAGUSD-5.16%XAGUSD-5.16%HG1-4.93%GAUUSD-1.33%XAUUSD-1.33%XNGUSD+1.26%S1+0.97%COTTON+0.95%W1+0.92%BTCUSD-1.60%ETHUSD-0.41%USDTUSD-0.03%XRPUSD-3.15%SOLUSD-2.06%TRXUSDT+0.18%ZECUSDT-8.90%DOGEUSD-3.20%XMRUSDT-0.36%LINKUSD-1.58%XLMUSD-1.64%BCHUSDT-10.50%LTCUSD-2.09%UNIUSD-2.09%TONUSD+24.88%HBARUSDT-2.57%SUIUSD-4.44%TAOUSDT-5.35%AAVEUSD-2.69%DOTUSDT-2.18%ICPUSDT-2.12%ONDOUSDT-3.45%WLDUSDT-3.15%ATOMUSDT-3.73%ARBUSDT-0.36%JUPUSDT-4.67%INJUSDT-3.45%STXUSDT-3.80%FETUSDT-3.74%TIAUSDT-1.39%PYTHUSDT-1.39%SEIUSDT-6.02%IMXUSDT-3.85%GRTUSDT-3.69%WIFUSDT-5.87%OPUSDT-4.00%POLUSDT-4.55%IOTAUSDT-4.04%AXSUSDT-2.68%FARTCOINUSDT-4.54%EOSUSDT-3.15%DYDXUSDT-2.64%ORDIUSDT-1.16%GALAUSDT-3.65%NOTUSDT-2.97%RONINUSDT-2.64%NVDA-2.45%AAPL+2.59%GOOGL+0.45%MSFT-0.04%AMZN-0.07%TSM-1.20%SPCX+1.15%AVGO-0.54%META-0.77%TSLA-0.64%SKHY-3.86%MU-4.52%BRK-B-0.16%LLY+0.40%JPM-0.53%WMT+0.12%AMD-2.80%V-0.31%XOM+0.85%ASMLa-1.66%JNJ+0.01%INTC-4.89%MA-0.58%0700.HK-1.94%1398.HK+0.79%ORCL-3.73%ABBV+0.69%BAC-0.47%CSCO-1.32%CVX-0.09%COST-0.15%KO+0.66%LRCX-4.97%CAT-1.40%AP2d-1.55%0005.HK-0.78%AMAT-2.47%UNH-0.55%HSBA.L-1.30%DELL-3.92%PG+0.14%MS-0.99%GE-0.74%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX+0.02%HD-1.60%0939.HK+1.66%GS-1.00%NZDJPY-2.57%AUDJPY-1.80%CHFJPY-1.58%NZDCAD-1.44%EURNZD+1.42%NZDUSD-1.38%GBPNZD+1.37%USDJPY-1.22%GBPJPY-1.21%EURJPY-1.20%CADJPY-1.15%NZDCHF-1.03%USDZAR+1.02%USDSEK+0.88%EURZAR+0.87%USDNOK+0.86%AUDNZD+0.80%GBPZAR+0.79%EURSEK+0.73%EURNOK+0.72%AUDCAD-0.68%AUDDKK-0.64%EURAUD+0.61%USDTHB+0.60%AUDUSD-0.58%GBPAUD+0.57%CHFSEK+0.57%CHFNOK+0.55%AUDSGD-0.53%USDMXN+0.44%CADCHF+0.42%USDPLN+0.41%GBPTRY+0.41%NZDSGD-0.40%EURCHF+0.38%USDCHF+0.37%GBPCHF+0.35%NOKJPY-0.34%GBPHKD+0.32%GBPMXN-0.28%SGDJPY+0.26%EURPLN+0.26%USDSGD+0.25%NZDMXN-0.23%AUDCHF-0.22%USDILS+0.16%EURHKD-0.16%USDDKK+0.15%USDTRY+0.11%PLNJPY+0.11%EURSGD+0.11%USDCNH+0.10%EURCZK-0.09%GBPCAD-0.08%AUDNOK+0.07%USDCAD-0.06%CHFSGD-0.06%EURCAD-0.05%USDCOP-0.04%EURGBP+0.03%EURCNH-0.03%GBPSGD+0.02%EURUSD+0.02%USDHKD+0.01%GBPUSD+0.01%EURDKK0.00%XPTUSD-5.82%UKOIL+5.74%USOIL+5.51%GAGUSD-5.16%XAGUSD-5.16%HG1-4.93%GAUUSD-1.33%XAUUSD-1.33%XNGUSD+1.26%S1+0.97%COTTON+0.95%W1+0.92%BTCUSD-1.60%ETHUSD-0.41%USDTUSD-0.03%XRPUSD-3.15%SOLUSD-2.06%TRXUSDT+0.18%ZECUSDT-8.90%DOGEUSD-3.20%XMRUSDT-0.36%LINKUSD-1.58%XLMUSD-1.64%BCHUSDT-10.50%LTCUSD-2.09%UNIUSD-2.09%TONUSD+24.88%HBARUSDT-2.57%SUIUSD-4.44%TAOUSDT-5.35%AAVEUSD-2.69%DOTUSDT-2.18%ICPUSDT-2.12%ONDOUSDT-3.45%WLDUSDT-3.15%ATOMUSDT-3.73%ARBUSDT-0.36%JUPUSDT-4.67%INJUSDT-3.45%STXUSDT-3.80%FETUSDT-3.74%TIAUSDT-1.39%PYTHUSDT-1.39%SEIUSDT-6.02%IMXUSDT-3.85%GRTUSDT-3.69%WIFUSDT-5.87%OPUSDT-4.00%POLUSDT-4.55%IOTAUSDT-4.04%AXSUSDT-2.68%FARTCOINUSDT-4.54%EOSUSDT-3.15%DYDXUSDT-2.64%ORDIUSDT-1.16%GALAUSDT-3.65%NOTUSDT-2.97%RONINUSDT-2.64%
AL

Altimmune, Inc. (ALT)

NASDAQ • Healthcare

$3.35
-$0 (-0.3%)
Market open

Last close at September 9, 2026 at 20:00 UTC

Open$3.35
Previous Close$3.35
Day Range$3.29 - $3.43
Avg. Volume (3M)4.1M
Market Cap$634.9M
52 Week Range
$2.56$6.44
Next EarningsIn 56 daysNov 5, 2026

Metrics Over Time

Fundamentals & Financials

Revenue (TTM)
$31K
Net Income (TTM)
-$91.7M
EPS (TTM)
-$0.78
ROA (TTM)
-17.4%
Current Ratio
26.78
Dividend Yield
0%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

-8.0%Q1 2026-$0.27
+28.0%Q2 2026-$0.18
+11.4%Q3 2026-$0.12
Next

Nov 5

in 56 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

View full earnings history

About Altimmune, Inc.

Altimmune, Inc. develops immune-focused drug candidates as a clinical-stage Biotechnology company listed on the NASDAQ as ALT. The company centers on two programs, pemvidutide and HepTcell, operates from Gaithersburg, Maryland, and traces its history to a 1997 founding as Vaxin Inc.

Name
Altimmune, Inc.
CEO
Jerome Benedict Durso
Website
altimmune.com
Industry
Healthcare
Year Founded
1997
Employees
57

Today's Snapshot

AI-generated

ALT is trading 2.4% lower at 3.27, while its sector was flat. Altimmune discussed pemvidutide, its experimental obesity drug, at a Wells Fargo healthcare conference.

Trading Volume

Below 10d avg (3.3M)

1.2M

vs S&P 500 Today

Underperforming Market

-1.83%

Updated: September 10, 2026 at 17:08 UTC

Technical Indicators

5 Buy2 Neutral1 Sell
ALT presents a strong buy profile driven by a clear trend and broad moving-average support despite being below the 200-day level. ADX is elevated, indicating a robust trend, while short- and medium-term SMAs/EMAs sit under the current price and MACD and momentum readings are mildly positive. VWAP aligns with price and ATR signals moderate volatility. OBV is negative in absolute terms but flagged as supportive in recent signal context, suggesting the move has accompanying accumulation signals. Technical takeaway: Strong Buy — strong trend and aligned short-to-intermediate moving averages with momentum confirmation.
All signals
  • EMA (5 indicators)$3.08 - $3.53
    Buy
  • RSI (14)56.81
    Neutral
  • Stochastic %K (14, 3, 3)64.37
    Neutral
  • MACD Level (12, 26)0.09
    Buy

Peers & Related Assets

AURAAura Biosciences, Inc.
$7.2-2.2%
ANNXAnnexon, Inc.
$4.37-6.4%
LRMRLarimar Therapeutics, Inc.
$3.87-5.2%
KRROKorro Bio, Inc.
$12.93-4.3%
LBRXLB Pharmaceuticals Inc Common Stock
ANROAlto Neuroscience, Inc.
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.